Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Wan-Xin Peng,Fei Liu,Jia-Hong Jiang,Hang Yuan,Ziqiang Zhang,Liu Yang,Yin-Yuan Mo
DOI: https://doi.org/10.1016/j.gendis.2024.101352
2024-06-15
Abstract:[This corrects the article DOI: 10.1016/j.gendis.2022.02.014.].
What problem does this paper attempt to address?